Cancer-causing bacteria gains antibiotic resistance finds KMC Scientists

Image
ANI
Last Updated : Jul 10 2019 | 3:15 PM IST

A study by the Kasturba Medical College and tertiary care hospital said to be first of its kind from Karnataka, has found that Helicobacter pylori, a bacterium that resides in the human stomach and causes ulcers, gastritis and stomach cancers, has gained resistance to three commonly used antibiotics - metronidazole, levofloxacin and clarithromycin that the drugs may not be able to provide relief anymore.

This important finding was the result of the joint collaboration of KMC, MAHE Scientists and Scientists from Marshall Centre, the University of Western Australia. The KMC Scientists were: Dr Mamatha Ballal (Team Lead), Dr Vignesh Shetty, Dr Ganesh Pai, Dr Ramachandra L, Dr Shiran Shetty and the UWA Scientists: Dr Alfred Tay, Dr Eng Guan Chua and Binit Lamichhane.

The study was aimed to gain insight on the prevalence and mechanism of drug resistance in Helicobacter linked diseases so as to help develop strategies with more rational antibiotic combinations for treatment. This will also help implement precise therapy and thus prevent recurrence of the infections.

"The KMC team was a truly interdisciplinary team which put together expertise across disciplines to reach these findings. Dr Vignesh Shetty trained with a Nobel Laureate, Professor Barry Marshall. Using highly advanced methods and skills, what could have remained as a lab bench technique has been brought to the bedside for better patient care", said Dr Pragna Rao, Dean, KMC.

This study can act as a strong foundation to progress in national epidemiological surveillance which will be beneficial in evidence-based treatment and also as a managerial follow-up of eradication of Helicobacter if the first line treatment fails. The working group at KMC in future plans to come out with a rapid kit for detection of drug resistance in bacteria, which would help clinicians to modulate treatment regimen.

This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 10 2019 | 2:57 PM IST

Next Story